Grantham, Mayo, Van Otterloo & Co (GMO)’s Carter's CRI Stock Holding History
Bought
Maintained
Sold
Other funds holding CRI
RI
Grantham, Mayo, Van Otterloo & Co (GMO)'s CRI Position: Q2 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) increased its Carter's (CRI) stake by 1.5% in Q2 2026, buying an estimated $11.5K and bringing the position to 20,894 shares worth $860K. The position accounts for ﹤0.01% of the portfolio, ranked #532.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CRI in Q2 2013 and has held it in 18 quarters since. The position peaked at $3.05M in Q4 2022. 287 funds tracked by Wall St. Rank hold CRI as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 20,894 shares of Carter's worth $860K as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) bought 304 Carter's shares in Q2 2026, an estimated $11.5K.
- Carter's made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #532 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Carter's in Q2 2013 and has held it in 18 quarters since.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Carter's position peaked at $3.05M in Q4 2022.
- 287 funds tracked by Wall St. Rank held Carter's as of Q2 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.